<DOC>
	<DOCNO>NCT01005108</DOCNO>
	<brief_summary>Overall Objectives : The overarch goal compare effectiveness acupuncture gabapentin respective placebo control treatment hot flash breast cancer patient . The investigator primary specific aim focus determine magnitude response placebo acupuncture versus placebo pill hot flash ( HFs ) .</brief_summary>
	<brief_title>Acupuncture Gabapentin Hot Flashes Among Breast Cancer Survivors</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Women 18 year old history Stage I , II III breast cancer least 12 month . 2 . Have see oncologist within previous 6month period determine free disease clinical examination history ; 3 . Experienced least two hot flash daily sevenday screen period base Daily Hot Flash Diary . 4 . Hot flash present least month study entry . 5 . Willing use nonhormonal contraceptive duration study patient premenopausal . 1 . Having metastatic breast cancer ( IV ) 2 . Currently chemotherapy radiation therapy adjuvant treatment 3 . Started hormonal therapy tamoxifen aromatase inhibitor within last 4 week ; plan change terminate hormonal therapy next 14 week . 4 . Started changed treatment hot flash , SSRIs clonidine within last 4 week ; plan change terminate therapy next 14 week . 5 . Current use estrogen and/or progestin . 6 . Pregnancy 7 . Breast feed 8 . Bleeding disorder current use warfarin heparin patient history use needle . 9 . Previous use gabapentin hot flash . 10 . Current use anticonvulsant . 11 . Renal dysfunction define serum creatinine concentration 1.25 time upper limit normal 12 . Known allergy gabapentin .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hot Flashes Breast Cancer Patients</keyword>
</DOC>